Pricing, Reimbursement, and Market Accessangelynng2021-02-03T17:35:27-05:00
Navigate a Complex Policy and Payment Environment to Unlock Value
Payers and health systems are seeking value, demanding more from novel drugs, devices, and diagnostic technologies than ever before. Stakeholders need to understand how new technologies and services deliver better outcomes and an improved patient experience while controlling costs. Boston Healthcare has a deep understanding of the global payer landscape, including government and private payers. We also go beyond policy makers to understand financial risk at the hospital or health system level, to better align the value our clients deliver with the expectations of reimbursement and funding stakeholders.
Boston Healthcare’s global panel of payer and health technology assessment leadership, combined with a rigorous understanding of the clinical and economic burden of disease, allows us to build strategic reimbursement roadmaps that address everything from coding, to policy, pricing, and evidence development. And with our implementation expertise, BHA is with you every step of the way, delivering the tools that help you communicate and capture value.
Reimbursement Assessment and Strategy
Evidence and Market Access Roadmap
Coding Analysis and Implementation
Value Communication Tools
Decision Impact Studies
Patient Preference Studies
Optimizing Pricing Strategies for a Medical Device Product Family
Global Market Access Strategy for Companion Diagnostic Test
US Market Access and Commercialization Planning for Novel Genomic Test
Reimbursement and Evidence Development Strategy for Therapeutic Device
Building a Global Market Access Capability for a Medical Device Organization